<DOC>
	<DOC>NCT01249196</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.</brief_summary>
	<brief_title>A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Clinical diagnosis of probable Alzheimer's disease(DSMIV and NINCDSADRDA criteria) MRI within the last 12 months consistent with a diagnosis of AD MMSE score of 10 to 26 and CDR of 1 or 2 AChEI or memantine was not taken at least 3 months prior to screening Other central nervous disease Hypothyroidism, Vitamin B12/ Folic acid deficiency, Hypercalcemia, Neurosyphilis, AIDS T.I.A or Major infarction within the last 12 months Any serious disorder that could limit the ability of the patient to participate in the study COPD or asthma Any condition which would make the patient or the caregiver, in the opinion of the investigator, unsuitable for the study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>